Prime Medicine, Inc. (PRME) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 38 days, typically, give or take 10 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 12, 2026after close 43 8-K
Q2 FY2026Thu, Aug 6, 2026before open 37 8-K
Q1 FY2026Thu, May 7, 2026before open 37 8-K
Q4 FY2025Tue, Mar 3, 2026before open 62 8-K
Q3 FY2025Fri, Nov 7, 2025before open 38 8-K
Q2 FY2025Thu, Aug 7, 2025before open 38 8-K
Q1 FY2025Thu, May 8, 2025before open 38 8-K
Q4 FY2024Fri, Feb 28, 2025before open 59 8-K

What they guided beta

Q3 FY2026 "Document Exhibit 99.1 Prime Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates -- First patient dosed in global Phase 1/2 clinical trial of PM577a in Wilson disease, the first clinical study of an in vivo Prime Editing therapy from Prime Medicine; initial clinical data expected in 2027 -- -- Received FDA clearance of Investigational New Drug application for PM647 in Alpha-1 Antitrypsin Deficiency; initial clinical data expected in 2027 -- -- Planning for a BLA submission for PM359 in the first half of 2027 -- -- Closed underwritten public offering, including th" exhibit
Q3 FY2026 "Looking ahead, we expect 2027 to be a meaningful year for the patient communities we hope to treat, with initial clinical data anticipated from both PM577a and PM647 and a planned BLA submission for PM359.”" exhibit
Q3 FY2026 "Initial clinical data are expected in 2027." exhibit
Q3 FY2026 "Initial clinical data are expected in 2027." exhibit
Q3 FY2026 "Financial Guidance Based on its current operating plans, Prime Medicine expects that its cash, cash equivalents and investments as of September 30, 2026, together with net proceeds from its follow-on public offering of $134.7 million in November 2026, will be sufficient to fund its operating expenses and capital expenditure requirements through 2027." exhibit
Q3 FY2026 "19 Trial Overview Design Phase 1/2, open-label Population Adults and adolescents with Wilson Disease and at least one ATP7B p.H1069Q allele Treatment Single IV infusion of PM577a Primary Endpoints Safety and tolerability Key Secondary Endpoints Ability to discontinue SOC, NCC-Sp, ceruloplasmin, 24-hour urinary copper and radiolabeled CuPET Dose Escalation Dose Cohort 1 Dose Cohort 2 Dose Cohort 3 Dose Cohort 4+ (if required) Part 1 (Extension) Adults stable on SOC Identify Optimal Biologic Dose Part 2 Adolescents stable on SOC OBD = Optimal Biological Dose; NCC = Non-Ceruloplasmin-bound" exhibit
Q3 FY2026 "25 Trial Overview Design Phase 1/2, open-label Population Adults with PiZZ AATD: lung-only (Group A) or lung + liver / liver-only disease (Group B) Treatment One-time IV infusion of PM647a Primary Endpoints Safety, tolerability Key Secondary Endpoints Serum AAT thresholds and isoforms; pulmonary and liver measures Dose Escalation Dose Cohort 1 Dose Cohort 2 Dose Cohort 3 Cohort 4+ (if required) Identify Optimal Biologic Dose AATD = Alpha-1 Antitrypsin Deficiency; BAL = Bronchoalveolar Lavage; DLT = Dose-Limiting Toxicity; FIH = First-in-Human; MTD = Maximum Tolerated Dose; OBD = Optimal " exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/PRME
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/PRME

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

PRME earnings date badge

HTML

<a href="https://veritasdata.dev/company/PRME/"><img src="https://veritasdata.dev/embed/PRME.svg" alt="PRME earnings date" width="240" height="56"></a>

Markdown

[![PRME earnings date](https://veritasdata.dev/embed/PRME.svg)](https://veritasdata.dev/company/PRME/)

Script

<script async src="https://veritasdata.dev/embed/PRME.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/PRME"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.